Abstract
The ε4 allele of the apolipoprotein E gene (APOE) has been associated with an increased risk of developing Alzheimer's disease (AD; refs 1,2). However, it is apparent that the APOEε4 allele alone is neither necessary nor sufficient to cause the disease3–5. We have recently found three new polymorphisms within the APOftranscriptional regulatory region (M.J.A. et al., manuscript submitted) and now establish an association between one of these polymorphisms (−491A/T) and dementia as observed in Alzheimer's disease, in two independent clinical populations. The results suggest that homozygosity of a common variant (−491 A) is associated with increased risk for AD, and that this association is independent of APOEs4 status. In vitro studies suggest that the −491 A/T polymorphism may increase risk for AD by altering the level of ApoE protein expression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
£139.00 per year
only £11.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Corder, E.H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of AD in late onset families. Science 261, 921–923 (1993.)
Strittmatter, W.J. et al. Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 1977–1981 (1993).
Institute on Aging/Alzheimer's Association Working Group. Apolipoprotein E genotyping in Alzheimer's disease. Lancet 347, 1091–1095 (1996).
Payami, H., Kaye, J., Heston, L.L., Bird, T.D. & Schellenberg, G.D. Apolipoprotein E genotypes and Alzheimer's disease. Lancet 342, 737–738 (1993).
Bennet, C. et al. Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's disease but is not causative. Am. J. Med. Genet. 60, 1–6 (1995).
Santana, M.A. et al. Neuropsychology and Apolipoprotein E genotype in Alzheimer's disease. J. Neurol. (Supp. 2) 243, 591 (1996).
Lendon, C.L. et al. Genetic Association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population. Neurosci. Lett. 222, 187 (1997).
Blesa, R. et al. High apolipoprotein E epsilon 4 allele frequency in age-related memory decline. Ann. Neurol. 39, 548–551 (1996).
Muros, M. & Rodriguez-Ferrer, C. Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4. Atherosclerosis 121, 13–21 (1996).
Miyata, M. & Smith, J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and b-amyloid peptides. Nature Genet. 14, 55–61 (1996).
Yamada, T., Kondo, A., Takamatsu, J., Tateishi, J. & Goto, I. Apolipoprotein E mRIMA in the brains of patients with Alzheimer's disease. J.Neurol. Sci. 129, 56–61 (1995).
Lambert, J.C. et al. Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. Hum. Mol. Genet. 6, 2151–2154 (1997).
Taddei, K., Clarnette, R., Gandy, S.E. & Martins, R.N. Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease. Neurosci. Lett. 223, 29–32 (1997).
McKhann, G. et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939–944 (1984).
Berg, L. & Morris, J.C. Alzheimer's disease. (Terry, R.D., Katzman, R. & Bick, K., eds.) 9–21 (New York, Raven Press, 1994).
Hixson, J.E. & Vernier, D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J.Lipid Res. 31, 545–548 (1990).
Garcia, M.A., Vázquez, J., Giménez, C., Valdivieso, F. & Zafra, F. Transcriptional factor AP-2 regulates human apolipoprotein E gene expression in astrocytoma cells. J. Neurosci. 16, 7550–7556 (1996).
Higuchi, R. PCR Protocols. (Innis, M.A., Gelfand, D.H., Sninsky, J.J. & White, T.J., eds.) 177–183 (New York: Academic Press, 1990).
Dignam, J.D., Lebovitz, R.M. & Roeder, R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acid Res. 11, 1475–1489 (1983).
Morris, J.A. & Gardner, M.J. Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. British Med. J. 296, 1313–1316 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bullido, M., Artiga, M., Recuero, M. et al. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet 18, 69–71 (1998). https://doi.org/10.1038/ng0198-69
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0198-69